Meta’s AI Tug-of-War: Using Leveraged ETFs to Trade the Muse Hype

Meta Platforms is officially entering its next phase, and Wall Street is taking notice. Shares of the tech giant are experiencing a sweeping re-rating as Muse, the company’s new AI agent, takes center stage in its roadmap and captures the attention of the broader investment community.No longer just a chat interface, Meta is aggressively pushing to entrench Muse across shopping, budgeting, browsers and even physical wearables like smart glasses. Nevertheless, this aggressive rollout has led to a fierce tug-of-war in the market.Key Takeaways:
The aggressive rollout of its new AI agent, “Muse,” is driving a sweeping market re-rating and intense stock fluctuation.
Bulls view Muse as a massive new monetization engine, while bears warn of heavy capex burn and platform friction.
Active traders can capitalize on this tug-of-war using single-stock funds like the Direxion Daily META Bull 2X ETF (METU A) and the Direxion Daily META Bear 1X ETF (METD B+).
Meta’s stock is currently caught between fresh analyst target hikes on one side, and rising concerns over intense AI capital expenditures, regulatory friction, and the actual timeline for monetization on the other.
With the market sharply divided between bulls and bears, active traders can use single-stock leveraged and inverse ETFs to profit from the volatility.The Bull Case: A Massive New Revenue EngineFor the optimists, Muse is the answer to unlocking Meta’s next era of growth. Bullish analysts are betting on the AI agent becoming a powerful new monetization engine, boosted by stronger ad tools and the future optionality of Reality Labs hardware.
Confidence in this AI-driven revenue tactic is also strong, with some bullish analysts recently raising their price targets on Meta stock into the $810 to $920 range. Shares of the company jumped roughly 13% over the past week and are on track to have their strongest month since July 2013.
Investors who believe Meta will successfully scale and monetize Muse while maintaining its dominant market position can increase their exposure using daily leveraged ETFs, like the Direxion Daily META Bull 2X ETF (METU A).
These single-stock ETFs offer the precise tools traders need to either double their gains on a technical rebound or hedge against ongoing downturns with inverse exposure.
Over the past two weeks, METU has seen substantial volatility but overall growth as well. For the first half of September, the fund began trading in the $26 range, closing at $26.44 on September 14.
After reaching a high close of $35.39 on September 24, the fund’s price has pulled back over the last few trading days, settling at around $30.22 as of intraday trading on September 28.The Bear Case: Cash Flow Pressure and Platform FrictionSkeptics of Muse argue that the market is severely underestimating the costs and operational hurdles of Meta’s AI ambitions. Recent headlines have noted that Amazon blocked Muse from shopping on its site, stating “disclosure and credential concerns” as its reason.
Bears also highlight Meta’s heavy capex burden, continuous losses from its investment in Reality Labs, ongoing severance costs, and lingering legal violations. A noticeable drop in the company’s Q2 free cash flow has worried some investors who question whether the AI spending spree will drag on margins before delivering a tangible payoff.
Investors who take the bearish perspective on Muse also have an ETF option from Direxion, the Direxion Daily META Bear 1X Shares (METD B+).
Even with the disagreements between skeptics and optimists on Meta’s big push for Muse, most traders and investors agree that the move is undeniably bold. As the gap between the bullish growth narrative and the bearish cash-flow reality broadens, increased volatility is almost guaranteed, making METU and METD critical tools for tactical traders.
For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.